About Nectome
Nectome is a company based in San Francisco (United States) founded in 2015 by Robert McIntyre and Michael McCanna. Nectome operates in a competitive market with competitors including Brooks Automation, Hemanext, Bridge to Life, Cellbox Solutions and Atelerix, among others.
- Headquarter San Francisco, United States
- Founders Robert McIntyre, Michael McCanna
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Nectome
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2018 | Amount | Seed - Nectome | Valuation |
investors |
Investors in Nectome
Nectome has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nectome
Financial Statements - Nectome
Nectome Comparisons
Competitors of Nectome
Nectome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Brooks Automation, Hemanext, Bridge to Life, Cellbox Solutions and Atelerix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vacuum robots for semiconductor wafer handling are developed.
|
|
| domain | founded_year | HQ Location |
Technologies for blood and product storage are developed.
|
|
| domain | founded_year | HQ Location |
Cold storage solutions for organ transplant preservation are provided.
|
|
| domain | founded_year | HQ Location |
Portable devices for cell storage and transport are provided.
|
|
| domain | founded_year | HQ Location |
Technology for cell storage and transportation is developed.
|
|
| domain | founded_year | HQ Location |
Platform for cryostorage and long-term biological preservation is provided.
|
Latest news on Nectome
Frequently Asked Questions about Nectome
Nectome was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Nectome is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Robert McIntyre is the current CEO of Nectome. They have also founded this company.
The company was founded in 2015 in San Francisco, United States, focusing on biotechnology for brain preservation. Techniques employed include fixation with glutaraldehyde to stabilize synapses and halt decay, altering the brains watery state to a rubber-like consistency. This is followed by vitrification at -122C for extended storage. Such methods, established over decades for biological specimens like organs and animals, support long-term preservation services in the sector.
Nectome's top competitors include Brooks Automation, Hemanext and Bridge to Life.
Nectome has 1 investor. Key investors include Y Combinator.